Quick Answer: Turkey Tail mushroom (Trametes versicolor) is one of the most extensively researched medicinal mushrooms globally, primarily recognized for its potent immunomodulatory properties. Its key active compounds, Polysaccharide K (PSK, also known as Krestin) and Polysaccharide-Peptide (PSP), have been the subject of numerous clinical trials, particularly in Japan and China, where they are approved as adjunct therapies for cancer. These compounds work by enhancing immune cell activity, such as natural killer (NK) cells and T-lymphocytes, and may also offer prebiotic benefits, supporting gut health. Turkey Tail Mushroom: The Most Clinically Studied Mushroom in the World Turkey tail ( Trametes versicolor ) is indeed the most clinically studied mushroom in the world, a testament to its profound therapeutic potential. Its primary active compound, PSK (polysaccharide-K, also called Krestin), has been the subject of over 400 clinical trials, predominantly in Japan, where it has been approved as a cancer adjunct therapy since 1977. This comprehensive review delves into the scientific evidence supporting Turkey Tail\'s role in immune modulation, cancer support, and other emerging health benefits. The Powerhouse Compounds: PSK and PSP The therapeutic efficacy of Turkey Tail mushroom is largely attributed to its unique polysaccharide compounds, primarily PSK and PSP. These proteoglycans are complex carbohydrate molecules bound to proteins, which are known for their significant biological activities, particularly in immune system modulation. PSK: The Most Studied Mushroom Compound PSK is a protein-bound polysaccharide extracted from Turkey Tail. It was developed as a pharmaceutical product in Japan in the 1970s and has been covered by Japan\'s national health insurance since 1977 [NCI, 2024]. The clinical evidence for PSK is primarily in oncology, specifically as an adjunct to chemotherapy and radiation for various cancers. Research indicates that PSK can enhance the body\'s natural defense mechanisms, helping to combat cancer cells and mitigate the immunosuppressive effects of conventional cancer treatments [Fisher & Yang, 2002]. PSP: The Chinese Counterpart PSP (polysaccharide-peptide) is a similar compound found in Turkey Tail that has been studied primarily in China. It shares many immunomodulatory properties with PSK and has been used as a cancer adjunct therapy in China since the 1980s [PubMed, 2015]. Studies have shown that PSP can restore weakened immune responses often observed in cancer patients undergoing chemotherapy, contributing to improved patient outcomes [PubMed, 2015]. Clinical Evidence in Cancer Support The most compelling body of evidence for Turkey Tail mushroom, particularly PSK, comes from its extensive use and research in cancer treatment. Its approval as an adjunct therapy in Japan and China highlights its recognized role in integrative oncology. The Japanese Cancer Trials Numerous randomized controlled trials (RCTs) and meta-analyses conducted in Japan have demonstrated the efficacy of PSK in improving survival rates and quality of life for cancer patients when used alongside conventional treatments. Gastric Cancer A meta-analysis of 8 RCTs involving 8,009 patients found PSK supplementation alongside chemotherapy significantly improved 5-year survival rates compared to chemotherapy alone. The effect was consistent across multiple chemotherapy regimens [PMC, 2023]. This suggests that PSK provides a robust supportive role, enhancing the effectiveness of standard treatments and potentially reducing recurrence [ASCO Post, 2015]. Colorectal Cancer Multiple RCTs have found PSK improves disease-free survival in colorectal cancer patients receiving adjuvant chemotherapy [ASCO Post, 2015]. By bolstering the immune system, PSK helps the body to better eliminate residual cancer cells, thereby reducing the risk of relapse [Kobayashi et al., 1995]. Breast Cancer A 2012 NIH-funded trial (the first FDA-approved clinical trial of a mushroom supplement in the US) found Turkey Tail extract improved immune function markers in breast cancer patients after conventional treatment [NCI, 2024]. This research is crucial as it demonstrates the potential for Turkey Tail to aid in recovery and immune restoration post-treatment, which is vital for long-term health and preventing recurrence. Furthermore, ongoing research, such as a phase II trial at Mayo Clinic, is investigating how Turkey Tail works in treating post-menopausal women with specific types of breast cancer [Mayo Clinic, 2026]. Mechanism of Action: How Turkey Tail Boosts Immunity The immunomodulatory effects of PSK and PSP are well-documented, primarily through their ability to activate key components of the immune system. This makes Turkey Tail a valuable ally, especially when the immune system is compromised, such as during chemotherapy or chronic illness. Natural Killer (NK) Cells NK cells are a type of lymphocyte that plays a major role in the host-